Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eman G Youssef

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Mbio|June 30, 2025
A spatial transcriptomic atlas of the host response to oropharyngeal candidiasisSunna Nabeela, Hayden McSwiggin, Rubens Daniel Miserani Magalhaes, et al.
Plos Pathogens|May 11, 2018
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infectionPriya Uppuluri, Lin Lin, Abdullah Alqarihi, et al.
Science Translational Medicine|March 12, 2025
A humanized antibody against mucormycosis targets angioinvasion and augments the host immune responseYiyou Gu, Shakti Singh, Abdullah Alqarihi, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Preserving Vascular Integrity Protects Mice against Multidrug-Resistant Gram-Negative Bacterial InfectionTeclegiorgis Gebremariam, Lina Zhang, Sondus Alkhazraji, et al.
Nature Microbiology|January 19, 2021
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosisSameh S M Soliman, Clara Baldin, Yiyou Gu, et al.
Nature|November 8, 2023
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungalArun Maji, Corinne P Soutar, Jiabao Zhang, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Mbio|June 30, 2025
A spatial transcriptomic atlas of the host response to oropharyngeal candidiasisSunna Nabeela, Hayden McSwiggin, Rubens Daniel Miserani Magalhaes, et al.
Plos Pathogens|May 11, 2018
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infectionPriya Uppuluri, Lin Lin, Abdullah Alqarihi, et al.
Science Translational Medicine|March 12, 2025
A humanized antibody against mucormycosis targets angioinvasion and augments the host immune responseYiyou Gu, Shakti Singh, Abdullah Alqarihi, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Preserving Vascular Integrity Protects Mice against Multidrug-Resistant Gram-Negative Bacterial InfectionTeclegiorgis Gebremariam, Lina Zhang, Sondus Alkhazraji, et al.
Nature Microbiology|January 19, 2021
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosisSameh S M Soliman, Clara Baldin, Yiyou Gu, et al.
Nature|November 8, 2023
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungalArun Maji, Corinne P Soutar, Jiabao Zhang, et al.
Pageof 2